Michael T Boswell
Overview
Explore the profile of Michael T Boswell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richardson S, Mzindle N, Motlou T, Manamela N, van der Mescht M, Lambson B, et al.
J Virol
. 2024 Jul;
98(7):e0067824.
PMID: 38953380
Importance: The continued evolution of SARS-CoV-2 has resulted in a number of variants of concern. Of these, the Omicron sublineage is the most immune evasive. Within Omicron, the BA.4/5 sublineage...
2.
Motsoeneng B, Manamela N, Kaldine H, Kgagudi P, Hermanus T, Ayres F, et al.
Front Immunol
. 2023 Aug;
14:1231276.
PMID: 37600825
The kinetics of Fc-mediated functions following SARS-CoV-2 infection or vaccination in people living with HIV (PLWH) are not known. We compared SARS-CoV-2 spike-specific Fc functions, binding, and neutralization in PLWH...
3.
Boswell M, Maimela T, Hameiri-Bowen D, Riley G, Malan A, Steyn N, et al.
South Afr J HIV Med
. 2023 Feb;
24(1):1412.
PMID: 36751479
Background: HIV infection causes immune dysregulation affecting T-cell and monocyte function, which may alter coronavirus disease 2019 (COVID-19) pathophysiology. Objectives: We investigated the associations among clinical phenotypes, laboratory biomarkers, and...
4.
Richardson S, Kgagudi P, Manamela N, Kaldine H, Venter E, Pillay T, et al.
Cell Rep Med
. 2023 Jan;
4(1):100910.
PMID: 36603577
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4 and BA.5 variants caused major waves of infections. Here, we assess the sensitivity of BA.4 to binding, neutralization, and antibody-dependent...
5.
Moyo-Gwete T, Madzivhandila M, Mkhize N, Kgagudi P, Ayres F, Lambson B, et al.
J Virol
. 2022 Jul;
96(15):e0055822.
PMID: 35867572
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, several variants of concern (VOCs) have arisen which are defined by multiple mutations in their spike proteins. These VOCs...
6.
Kitchin D, Richardson S, van der Mescht M, Motlou T, Mzindle N, Moyo-Gwete T, et al.
Cell Rep Med
. 2022 Apr;
3(3):100535.
PMID: 35474744
The Janssen (Johnson & Johnson) Ad26.COV2.S non-replicating viral vector vaccine has been widely deployed for COVID-19 vaccination programs in resource-limited settings. Here we confirm that neutralizing and binding antibody responses...
7.
Richardson S, Madzorera V, Spencer H, Manamela N, van der Mescht M, Lambson B, et al.
Cell Host Microbe
. 2022 Apr;
30(6):880-886.e4.
PMID: 35436444
The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by vaccines or infection. However, whether Omicron triggers cross-reactive humoral responses to other variants of concern (VOCs) remains unknown. We used plasma...
8.
Keeton R, Tincho M, Ngomti A, Baguma R, Benede N, Suzuki A, et al.
Nature
. 2022 Apr;
604(7907):E25.
PMID: 35396582
No abstract available.
9.
Richardson S, Manamela N, Motsoeneng B, Kaldine H, Ayres F, Makhado Z, et al.
Cell Rep Med
. 2022 Mar;
3(2):100510.
PMID: 35233544
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from neutralizing antibodies, causing concern about vaccine effectiveness. However, while non-neutralizing cytotoxic functions of antibodies are associated with...
10.
Keeton R, Tincho M, Ngomti A, Baguma R, Benede N, Suzuki A, et al.
Nature
. 2022 Feb;
603(7901):488-492.
PMID: 35102311
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations that contribute to viral escape from antibody neutralization and reduce vaccine protection from infection. The extent to which other components...